Stocks and Investing Stocks and Investing
Wed, June 8, 2022
Tue, June 7, 2022
Mon, June 6, 2022
Sun, June 5, 2022
Fri, June 3, 2022
Thu, June 2, 2022

Kevin Caliendo Upgraded (XRAY) to Strong Buy and Decreased Target to $47 on, Jun 2nd, 2022


Published on 2024-10-27 21:23:51 - WOPRAI, Kevin Caliendo
  Print publication without navigation


Kevin Caliendo of UBS, Upgraded "DENTSPLY SIRONA Inc." (XRAY) to Strong Buy and Decreased Target from $58 to $47 on, Jun 2nd, 2022.

Kevin has made no other calls on XRAY in the last 4 months.



There are 9 other peers that have a rating on XRAY. Out of the 9 peers that are also analyzing XRAY, 6 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Yi Chen of "HC Wainwright & Co." Maintained at Hold with Decreased Target to $48 on, Friday, April 22nd, 2022
  • Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $47 on, Thursday, April 21st, 2022
  • Michael Cherny of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $49 on, Wednesday, April 20th, 2022
  • Jason Bednar of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $46 on, Wednesday, April 20th, 2022
  • Jeffrey Johnson of "Baird" Downgraded from Buy to Hold and Held Target at $48 on, Tuesday, April 19th, 2022
  • John Kreger of "William Blair" Downgraded from Buy to Hold on, Tuesday, April 19th, 2022


These are the ratings of the 3 analyists that currently disagree with Kevin


  • Erin Wright of "Morgan Stanley" Maintained at Buy with Decreased Target to $48 on, Wednesday, May 11th, 2022
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Decreased Target to $67 on, Tuesday, March 1st, 2022
  • Jeff Johnson of "Baird" Maintained at Buy with Decreased Target to $67 on, Friday, February 18th, 2022